Pharmacyte Biotech Inc (PMCB) is near the top in its industry group according to InvestorsObserver. PMCB gets an overall rating of 64. That means it scores higher than 64 percent of stocks. Pharmacyte Biotech Inc gets a 76 rank in the Biotechnology industry. Biotechnology is number 33 out of 148 industries.
PMCB has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on PMCB!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Pharmacyte Biotech Inc Stock Today?
Pharmacyte Biotech Inc (PMCB) stock has fallen -1.38% while the S&P 500 is up 0.47% as of 2:17 PM on Monday, Mar 27. PMCB is down -$0.04 from the previous closing price of $2.89 on volume of 49,790 shares. Over the past year the S&P 500 has fallen -12.80% while PMCB is up 21.79%. PMCB lost -$0.27 per share the over the last 12 months.
Click Here to get the full Stock Report for Pharmacyte Biotech Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
